ARCHIVES

FDA Approves Ribavirin Phase 102 Trials

This article is from The Cancer Letter archive.

Vol. 13 No. 42 | October 30, 1987

Download PDF Visit The Full Archive

Related Articles

Agencies Plan Better Reporting Of Adverse Events In Trials.

February 4, 2000

Avastin doubles progression-free survival in metastatic disease.

May 27, 2005

ASCO Foundation Renamed

February 18, 2011

ORI takes Over Misconduct Inquiry Of NSABP Officials

July 29, 1994

DES Study Indicates Threat If Vaginal Cancer May Not Be Serious

November 15, 1974

NCI Clinical Trials Enrollment Drops to 17,500

February 21, 2014